Zero Infinity Partners — 2025 Investments
3 investments dated 2025 · listed companies and verified rows first · show all
RxList is an online medical resource providing detailed pharmaceutical information on brand and generic drugs, written and reviewed by pharmacists and physicians.
Digital HealthHealthtechMedia & EntertainmentSan Clemente, US
Co-investorsHealthCapAlleyCorpAnzu PartnersIn-Q-TelMaverick SiliconSamsung Ventures+2 more
Deliver Biosciences develops a nanoparticle-based delivery platform to genetically engineer cells in patients for cell and gene therapies, targeting cancer immunotherapies as the first indication with applications in autoimmune, neurodegenerative, and cardiovascular diseases.
BiotechDeep TechMedical Devices
Co-investorsDeep Science VenturesCIVCostanoa VenturesForgePoint CapitalMoment Ventures, LlcRidge Ventures+1 more
A platform for qualitative research that recruits participants from a global panel or accepts brought-in participants and conducts AI-moderated interviews in 50+ languages.
AI & Machine LearningData & InfrastructureMarketing TechSaaS
Rick Song(Founder & CEO)inCharles Yeh(Founder)in
Co-investorsm]x[v CapitalEmbedded VenturesFathom FundFounders FundGOOSE CapitalIBK Capital+5 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.